Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Suriname has been steadily increasing over the years.
Customer preferences: Suriname has a diverse population with various skin types and conditions. As a result, the demand for dermatological drugs is high. Customers prefer products that are effective and affordable. They also prefer products that are easily accessible and can be purchased without a prescription.
Trends in the market: The dermatological drugs market in Suriname has been growing due to several factors. Firstly, the increasing prevalence of skin diseases and conditions has led to a higher demand for dermatological drugs. Secondly, the rise in disposable income has made it easier for customers to afford these products. Thirdly, the availability of a wider range of products has increased customer choice and satisfaction. Finally, the growing awareness of the importance of skincare has led to an increase in demand for dermatological drugs.
Local special circumstances: Suriname has a tropical climate, which makes it more prone to certain skin conditions such as fungal infections, sunburn, and insect bites. As a result, there is a higher demand for products that can treat these conditions. Additionally, the country has a high prevalence of skin conditions such as eczema and psoriasis, which also contributes to the demand for dermatological drugs.
Underlying macroeconomic factors: Suriname has a small economy that is heavily dependent on exports of natural resources such as gold and oil. The country has been facing economic challenges in recent years due to falling commodity prices and political instability. However, the healthcare sector has remained resilient, and the demand for dermatological drugs has continued to grow. This is partly due to the fact that skin conditions are not directly affected by macroeconomic factors such as GDP or inflation. Additionally, the government has made efforts to improve access to healthcare, which has contributed to the growth of the dermatological drugs market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
